Generate a tailored SOP for Dr. Nathalie Grandvaux. Improve your application with a focused, well-structured draft.
Nathalie Grandvaux's laboratory focuses on antiviral defense mechanisms, specifically innate immunity and inflammation. She completed her engineering degree and a master's in Biochemistry at the Institut National des Sciences Appliquées de Lyon before obtaining her Ph.D. from Université Joseph Fourier in 1999. Since her postdoctoral studies began in 2000, she has dedicated her research to understanding the innate immune response within the context of viral infections, particularly Respiratory Syncytial Virus (RSV). Her work aims to identify new therapeutic targets for viral infections and other diseases like HTLV-1 induced leukemias. At Université de Montréal, she has been instrumental in bridging basic research with clinical applications, collaborating with clinicians to apply her findings in real-world settings. Grandvaux emphasizes collaborative and multidisciplinary approaches in her research, having established partnerships with institutions in Canada, the United States, Belgium, and Australia. Her team's ongoing research enhances the understanding of host defense mechanisms against viral pathogens and explores innovative strategies for therapeutic applications.
Université de Montréal • Montréal, QC, Canada
Leading research on antiviral mechanisms and innate immune responses.
Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.